2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 14th inform suppl. M2-A8 and M7-A6.Wayne.Pennsylvania:NCCLS,2004.1-50.
3Francois P, Pittet D, Bento M, et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol, 2003,41:254-260.
4Wilcox MH, Fawley W. Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin. J Antimicrob Chemother, 2001,48:144-145.
5Chaitram JM, Jevitt LA, Lary S, et al. The world health organization′s external quality assurance system proficiency testing program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS method. J Clin Microbil, 2003, 41:2372-2377.
6Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylocococcus aureus isolate from a patient in Pennysylvania. Antimicrobial Agents Chemotherapy, 2004,48:275-280.
7Muhlemann K, Matter HC, Tauber MG, et al. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection Switzerland,1998-1999.J infect Dis,2003,187:589-596.
8Walsh TR, Bolmstrom A, Qwarnstrom A, et al. Evaluation of a new E test for detecting metallo-beta-lactamase in routine clinical testing. J Clin Microbiol, 2002,40:2755-2759.
